Related Experiment Video

Updated: Feb 12, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K

Effect of spleen tyrosine kinase on nonsmall cell lung cancer

Ying Tao Hao1, Chuan Liang Peng1, Yun Peng Zhao1

  • 1Department of Thoracic, The Second Hospital of Shandong University, Jinan, Shandong, China.

Journal of Cancer Research and Therapeutics
|March 27, 2018
PubMed
Abstract

Insights

Overexpressed spleen tyrosine kinase (Syk) inhibits nonsmall cell lung cancer cell invasion by reducing matrix metalloproteinase-9 (MMP-9) expression. This finding highlights Syk

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Nonsmall cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
  • Tumor invasion and metastasis are critical factors in NSCLC progression and patient outcomes.
  • The role of spleen tyrosine kinase (Syk) in NSCLC pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the anti-tumor effects of spleen tyrosine kinase (Syk) on human nonsmall cell lung cancer (NSCLC) cells.
  • To elucidate the underlying molecular mechanisms of Syk's action in NSCLC.

Main Methods:

  • Construction of a eukaryotic expression vector pcDNA3.1D/V5-His-TOPO/Syk.
  • Transfection of the Syk vector into human NSCLC A549 cells.
  • Analysis of Syk expression, cell invasion, and matrix metalloproteinase-9 (MMP-9) expression in transfected cells.

Main Results:

  • Overexpression of Syk significantly inhibited the invasive ability of A549 NSCLC cells.
  • Syk overexpression led to a decrease in the expression of matrix metalloproteinase-9 (MMP-9).

Conclusions:

  • Spleen tyrosine kinase (Syk) plays a significant role in regulating tumor invasion and metastasis in NSCLC.
  • Overexpressed Syk exhibits an inhibitory effect on human nonsmall cell lung cancer cell progression.
Keywords:
Invasionmatrix metalloproteinasenonsmall cell lung cancerspleen tyrosine kinase

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
561
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K